AstraZeneca Pharma India Limited has submitted a certificate dated January 6, 2026, issued by Integrated Registry Management Services Private Limited, the company's Registrar and Transfer Agents (RTA). This certificate confirms the company's compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The announcement was made on January 16, 2026, and the company has requested that this information be taken on record.